Management of venous thromboembolism

Journal of Association of Physicians of India

Volumn 55, Issue JAN., 2007, Pages 49-70

  Parakh, R ^a   Kakkar, V V ^b   Kakkar, A K ^c  

^a SIR GANGA RAM HOSPITAL   (India)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

HUMAN; INCIDENCE; INDIA; PRACTICE GUIDELINE; REVIEW; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ANTICOAGULANTS; HUMANS; INCIDENCE; INDIA; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 34247515660     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of Venous Thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST 2004;126:338S-400S, (Suppl 3).
2. Prevention of Venous thromboembolism: International Consensus Statement Guidelines compiled in accordance with the scientific evidence. Under the auspices of the cardiovascular Disease Educational and Research Trust, and the International Union of Angiology. International Angiology 2001;20:1-37.
3. http://www.rcog.org.uk/resources/Public/pdf/Thromboprophylaxisno037.pdf (accessed July 2006).
4. Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). Int Angiol Jun 2006;25:101-61.
5. http://www.nccn.org/professionals/physician gls/PDF/vte.pdf (accessed July 2006).
6. Prandoni P, Lensing AW, Cogo A, et al. The long term Clinical Course of Acute Deep Vein Thrombosis. Ann Intern Med 1996;125:1-7.
7. Agarwala S, Bhagwat A, Sharma A, et al. Local and general factors are the likely cause of venous thrombosis in lower limb arthroplasty. Thromb Haemost 2004;92:1167-9.
8. Geerts WH, Heit JA, Claget GP, et al. Prevention of Venous Thromboembolism. CHEST 2001;119:132-75S.
9. Samama MM, Cohen AT, Darmon JY, et al. A comparison of Enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793-800.
10. Todi Sk, Sinha S, Chakarborty A, et al. Utilization of DVT Prophylaxis in medical/Surgical Intensive care units. Indian Journal of Critical Care Medicine 2003;7:103-5.
11. Hirsh J, Warkentin TE, Shanghnessey SG, et al. Heparin and LMWH: Mechanism of action, Pharmacokinetic dosing, Monitoring efficacy and safety. CHEST 2001;119(Suppl-64S-94S).
12. Creager MA, Dzau VJ. Vascular diseases of the extremities, in Fauci AS, Martin JB, Braunwald E, et al (ed): Harrison's Principles of Internal Medicine 14 edition, 2001;pp 1403.
13. Lindblad B, Bergqvist D, Nordstrom M, Kjellstrom T, Bjorgell O, Nylander G, Sternby NH, Anderson H. [A survey in Malmo. The frequency of venous thromboembolism has not changed during the last 30 years] Lakartidningen 1992;89:2941-2, 2947.
14. Claget GP, Anderson FA jr, Heit J, et al. Prevention of Venous Thromboembolism. CHEST 1995;108 (Suppl:312S-334S).
15. Piovella F, Wang CJ, Lu H, Lee K, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on post-operative screening with centrally adjudicated bilateral Venography. J Thromb Haemost 2005;3:2664-70.
16. Dhillon KS, Askander A, Doraiswamy S. Post Operative DVT in Asian Patients is not a rarity: A prospective study of 88 patients with no Prophylaxis. Journal of Bone Joint Surgery Br 1996;78:427-30.
17. Kin YH, Suh JS. Low Incidence of Deep Vein Thrombosis after Cementless Total Hip Arthoplasty. J Bone Joint Surg Am 1988;70:878-82.
18. Shead GV, Narayan R. Incidence of Post Operative VTE in South India. British Journal of Surgery 1980;67:813-4.
19. Vijayraghavan KS, Sharma S, Pai VM, et al. DVT in South Indian Population. Indian Journal of Surgery 2001;63:199-201.
20. Jain V, Dhoan BK, Jaiswal A, et al. DVT after Total Hip and Knee Arthroplasty in Indian Patients. Post Graduate Medical Journal 2004;80:729-731.
21. Agarwala S, Bhagwat AS, Modhe J, et al. Incidence of DVT in Indian Patients. Indian Journal of Orthopedics 2003;37:159-62.
22. Leizorovicz A, et al. For the SMART Study Group. Epidemiology of venous throboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART Study. J Thromb Haemost 2005;3:28-34.
23. Pinlaja RK, Agarwal MB, TurpieAGG. A Characterization of Patients with symptomatic DVT in India, for PROVE Investigators.( Nizams Institute of Medical Sciences, Punjagutta, Hydrabad, India, Bombay Hospital Institute of Medical Sciences, Mumbai, India, McMaster University, HHS McMaster Clinic, Hamilton, Ontario, Canada) Journal of Thrombosis and Hemostasis 2005;3: P1043.
24. Parakh R, Kapadia F, Agarwal S, Grover t, et al. Assessment of total thrombus load in symptomatic patients with venous thromboembolism. Clin Appl Thrombosis/Hemostasis 2006;12:T1-T4.
25. Di Nisio M, Middeldorp S, Buller HR. Direct Thrombin Inhibitors. N Engl J Med 2005;353:1028-40.
26. Wells PS, Anderson DR, Rodger M, et al. Evaluation of d-Dimer in the diagnosis of Suspected Deep-Vein Thrombosis. N Engl J Med 2003;349.
27. Goodacre S, Sutton AJ, Sampson FC. Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005;143(2):129-39.
28. Crowther MA, Kelton JG. Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. Ann Intern Med 2003;138:128-34.
29. Haines ST, Bussey HI. Diagnosis of deep vein thrombosis. Am J Health-Syst Pharm 1997;54:66-74.
30. Agarwala S, Bhagwat AS, Modhe J. DVT in Indian patients undergoing major lower limb surgery. I J of Surgery 2003;65:159-162.
31. Agarwala S, Bhagwat AS, Modhe J, Wadhwani R. Screening for DVT in Post Operative Orthopedic Patients: Comparison of Color Doppler Sonography and Contrast Venography. Indian Journal of Surgery 2002;36:154-6.
32. [No Authors listed]. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990;263:2753-9.
33. Gould MK, Dombitzer AD, Doyle RL, et al. LMWH Compared with Unfractionated Heparin for Treatment of Acute DVT. A meta-analysis of Randomized Controlled Trial. Ann Inter Med 1999;130:800-09.
34. Merli G, Spiro TE, Olsson CG, et al. Subcutaneous Enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001;134:191-202.
35. Koopman MM, Prandoni P, Piovella F, et al. Treatment of Venous Thrombosis with intravenous Unfractionated Heparin administered in Patients with Cancer and Venous Thrombosis. Blood 2002;100:3484-88.
36. Greaves M. For the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Limitations of the laboratory monitoring of heparin therapy. Thromb Haemost 2002;87:163-64.
37. White RH, Ginsberg JS. Low-molecular-weight-heparin: are they all the same? Br J Haematol 2003;121:12-20.
38. Fareed J, Walenga JM, Hoppensteadt D, et al. Comparative study on the in vitro and in vivo activities of seven LMWH. Haemostasis 1988;18:3-15 (Suppl3).
39. Harenberg J, Siegele M, Dempfle CE, Stehle G, Heene DL. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins. Thromb Haemostat 1993;70:942-5.
40. Weitz JI. Low-Molecular-Weight-Heparins. N Engl J Med 1997;337:688-98.
41. Imperiale TF, Speroff T. A Meta-analysis of methods to prevent venous thromboembolism following Total Hip Replacement. JAMA 1994;271:1780-85.
42. Forestier F, Daffos F, Capella Pavlovsky M. LMWH (P10169) does not cross the placenta during the second trimester of pregnancy - Study by direct fetal blood sampling under ultrasound. Thromb Res 1984;34:557-60.
43. Hirsh J, Warkentin TE, Shanghnessey SG, et al. Heparin and LMWH: Mechanism of action, Pharmacokinetic dozing Monitoring efficacy and Safety. CHEST 2001;119:Suppl 64S-94S.
44. Lindhofflast E, Nakov R, Misselwitz F, et al. Incidence and Clinical Relevence of Heparin Induced Antibodies in patients with DVT treated with UFH or LMWH. Br J Haematol 2002;118:1137-42.
45. Schaffer A. Venous thrombosis as a chronic disease. N Engl J Med 1999;340:955-6.
46. Herbert JM, Herault JP, Bernat A, et al. Biochemical and Pharmacological Properties of SANORGA-34006, a potent and long acting synthetic pentasaccharide. Blood 1998;91:4197-4205.
47. Kay TW, Martin FI. Heel ulcers in patients with long-standing diabetes who wear anti-embolism stockings. Med J Aust 1986;145:290-1.
48. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis (Cochrane Review). The Cochrane Library, 2001; Issue 3.
49. Bergqvist D. Postoperative thromboembolism: frequency, etiology, prophylaxis. Berlin: Springer-Verlag; 1983.
50. Nicolaides AN, Arcelus J, Belcaro G, Bergqvist D, Borris LC, et al. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol 1992;11:151-9.
51. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. Arch Intern Med 1994;154: 67-72.
52. Wilkins RW, Mixter G, Stanton JR, Litter J. Elastic stockings in the prevention of pulmonary embolism: a preliminary report. N Engl J Med 1952;246:360-4.
53. Hui AC, Heras-Palou C, Dunn I, et al. Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement. J Bone Joint Surg Br 1996;78:550-4.
54. Williams JT, Palfrey SM. Cost effectiveness and efficacy of below knee against above knee graduated compression stockings in the prevention of deep vein thrombosis. Phlebologie 1988;41:809-11.
55. Porteus MJ, Nicholson EA, Morris LT. Thigh length versus knee length stockings in the prevention of deep vein thrombosis. Br J Surg 1989;76:296-7.
56. Kalodiki E, Nicolaides AN. Graded compression stockings for the prevention of deep-vein thrombosis. J Bone Joint Surg Br 1997;79:507-8.
57. Allan A, Williams JT, Bothom JP, et al. The use of GC stockings in the prevention of post operative DVT. Br J Surg 1983;70:172-4.
58. Comerota AJ, Chouhan V, Harada RN, et al. The fibrinolytic effects of intermittent pneumatic compression: Mechanism of enhanced fibrinolysis. Ann Surg 1997;226:306-13.
59. Handoll HHG, Farrar MJ, McBirnie J. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures (Cochrane Review). The Cochrane Library, Oxford 2001; Issue 3.
60. Gardner AM, Fox RH: The venous pump of the human foot - preliminary report. Bristol Med Chir J 1983;98:109-12.
61. Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty 1993;8:57-61.
62. Fordyce MJ, Ling RS. A venous foot pump reduces thrombosis after hip replacement. J Bone Joint Surg Br 1992;74: 45-9.
63. Stannard JP, Harris RM, Bucknell AL. Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. Am J Orthop 1996;25:127-34.
64. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am 1996;78:826-34.
65. Santori FS, Vitullo A, Stopponi M, et al. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg 1994;76:579-83.
66. Wilson NV, Das SK, Kakkar VV, et al. Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V Impulse System. J Bone Joint Surg 1992;74:50-2.
67. Blanchard J, Meuwly JY, Leyvraz PF, et al. Prevention of deep-vein thrombosis after knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999;81:654-9.
68. Warwick D, Harrison J, Glew D, et al. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998;80:1158-66.
69. Aaro LA, Juergens JL. Thrombophlebitis and pulmonary embolism as complications of pregnancy. Med Clin North Am 1974;58(4):829-34.
70. Saneja A, Arora RM, Agarwal N. Deep Vein Thrombosis in Pregnancy. Journal of Indian Academy of Clinical Medicine 2001;2:4;260-9.
71. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119(Suppl:176S-193S).
72. Decouses H, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N England Journal of Medicine 1998;338:409-15.
73. Lee AYY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999;25:137-45.
74. Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003;107,I-17-I-21.
75. Fisher B, Constantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with mode-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479-84.
76. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Ann Surg 1988;208:227-40.
77. Pardoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost 1997;78:141-44.
78. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000;160:3415-20.
79. Goldhaber SZ, Tapson VF. DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.